Author

Jessi L. Keavney

Observed name: Jessi Keavney

Institution: Parkinson's Foundation

Observed institutions: Northwestern University, San Francisco VA Medical Center, Harvard University, University of California, San Francisco, Columbia University Irving Medical Center, Critical Path Institute, Christian-Albrechts-Universität zu Kiel, Massachusetts General Hospital, Institute for Neurodegenerative Disorders, San Francisco VA Health Care System, Parkinson's Foundation

ORCID: 0000-0002-2568-9006

Observed ORCID: 0000-0002-2568-9006

OpenAlex ID: A5027236213

Path to Parkinson Disease Prevention: Conclusion and Outlook

2022 · Daniela Berg, Grace F. Crotty, et al. · Neurology · 34

Transforming Drug Development for Neurological Disorders: Proceedings from a Multidisease Area Workshop

2023 · Diane Stephenson, Ramona Belfiore-Oshan, et al. · Neurotherapeutics · 31

Planning for Prevention of Parkinson Disease: Now Is the Time

2022 · Grace F. Crotty, Jessi L. Keavney, et al. · Neurology · 31

Perspectives of People At-Risk on Parkinson’s Prevention Research

2024 · Jessi L. Keavney, Soania Mathur, et al. · Journal of Parkinson s Disease · 14

Slow-SPEED: protocol for three randomised trials of remotely delivered exercise to prevent Parkinson’s disease

2026 · Thomas H. Oosterhof, Eleanor Mitchell, et al. · npj Parkinson s Disease · 1

Correction: Transforming Drug Development for Neurological Disorders: Proceedings from a Multidisease Area Workshop

2023 · Diane Stephenson, Ramona Belfiore-Oshan, et al. · Neurotherapeutics

Works count: 6

Citation count: 111

H-index: 4

I10-index: 4